Literature DB >> 16263740

Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.

Leyi Gu1, Shinji Hagiwara, Qiuling Fan, Mitsuo Tanimoto, Mami Kobata, Michifumi Yamashita, Tomohito Nishitani, Tomohito Gohda, Zhaohui Ni, Jiaqi Qian, Satoshi Horikoshi, Yasuhiko Tomino.   

Abstract

BACKGROUND: Upregulation of local monocyte chemoattractant protein-1 (MCP-1) production is involved in glomerular damage through macrophage recruitment and activation in diabetic nephropathy. Treatment of db/db mice with soluble receptor for advanced glycation end-products (RAGE) prevented recruitment of macrophages to the glomeruli and reduced albuminuria, suggesting that binding of ligands and RAGE may be involved in MCP-1 expression. Therefore, we investigated the role of advanced glycation end-products (AGEs) in MCP-1 production by podocytes and signalling events after RAGE activation.
METHODS: MCP-1 gene and protein expression were examined by using reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay in differentiated mouse podocytes. Dichlorofluorescein-sensitive intracellular reactive oxygen species (ROS) generation was measured by confocal microscopy. RAGE, phosphorylation of mitogen-activated protein kinases, nuclear factor (NF)-kappaB, c-Jun and Sp1 were studied using western blotting and immunocytochemistry.
RESULTS: Both differentiated and undifferentiated podocytes expressed RAGE. MCP-1 was induced by AGEs and carboxymethyllysine (CML) in a time-dependent and dose-dependent manner in differentiated podocytes. Neutralizing antibody for RAGE suppressed AGE- and CML-induced MCP-1 production. AGEs and CML rapidly generated intracellular ROS in podocytes. Blocking of ROS by using N-acetyl-l-cysteine abolished CML and H(2)O(2)-induced MCP-1 expression. Phosphorylated extracellular signal-regulated kinase (ERK) was found in podocytes incubated with CML and was prevented by N-acetyl-l-cysteine or 7'-amino 4 [trifluoromethyl]. PD98059, an inhibitor of ERK, partially prevented CML-induced MCP-1 gene expression. NF-kappaB and Sp1 were translocated into the nucleus after podocytes were incubated with CML for 60 min. Parthenolide and mithramycin A, inhibitors of NF-kappaB and Sp1, respectively, abolished CML-induced MCP-1 gene expression in a dose-dependent manner.
CONCLUSIONS: These results suggest that AGEs and CML induce MCP-1 expression in podocytes through activation of RAGE and generation of intracellular ROS. NF-kappaB and Sp1 regulate MCP-1 gene transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263740     DOI: 10.1093/ndt/gfi210

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  38 in total

Review 1.  RAGE and the pathogenesis of chronic kidney disease.

Authors:  Vivette D'Agati; Ann Marie Schmidt
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

2.  Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.

Authors:  Bo Feng; Lei Xu; Hua Wang; Xinfeng Yan; Junli Xue; Fengjing Liu; Ji-Fan Hu
Journal:  Biochim Biophys Acta       Date:  2011-05-30

Review 3.  What are new avenues for renal protection, in addition to RAAS inhibition?

Authors:  Shinji Hagiwara; Phillip Kantharidis; Mark E Cooper
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 4.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

Authors:  Federica Barutta; Graziella Bruno; Serena Grimaldi; Gabriella Gruden
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

Review 5.  The Prevalence and Management of Diabetic Nephropathy in Asia.

Authors:  Yasuhiko Tomino; Tomohito Gohda
Journal:  Kidney Dis (Basel)       Date:  2015-04-30

6.  Abnormalities in signaling pathways in diabetic nephropathy.

Authors:  Frank C Brosius; Charbel C Khoury; Carolyn L Buller; Sheldon Chen
Journal:  Expert Rev Endocrinol Metab       Date:  2010

Review 7.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

8.  Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Yayoi Kurita-Nakamura; Takanori Matsui; Takafumi Yoshida; Tsutomu Imaizumi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

9.  The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.

Authors:  Eun Young Lee; Choon Hee Chung; Charbel C Khoury; Tet Kin Yeo; Petr E Pyagay; Amy Wang; Sheldon Chen
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-06

Review 10.  NOX enzymes and diabetic complications.

Authors:  Tomoko Kakehi; Chihiro Yabe-Nishimura
Journal:  Semin Immunopathol       Date:  2008-05-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.